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Abstract 
Calcium (Ca2+) plays a central role in regulating many biological processes in the cell from muscle contraction 
to neurotransmitter release. The need for reliable fluorescent calcium indicator dyes is of vast importance for 
studying many aspects of cell biology as well as screening compounds using phenotypic high throughput assays. 
We have assessed two of the latest generation of calcium indicator dyes, FLIPR Calcium 6 and Cal-520 AM for 
studying calcium transients (CaTs) in induced pluripotent stem cell (iPSC) -derived human cardiomyocytes. 
FLIPR Calcium 6 and Cal-520 dyes both displayed robust CaTs with a high signal-to-noise ratio (SNR) and were 
non-toxic to the cells. The analysis showed that CaT amplitudes were stable between measurements, but CaT 
duration was more variable and tended to increase between reads. Two methods were compared for drug-
screening hit-selection; difference in average (unstandardized) and standardized difference. The unstandardized 
difference was better for assessing CaT amplitude, whereas standardized difference was equal to or better for 
assessing CaT duration. In summary, FLIPR Calcium 6 and Cal-520 are suitable dyes for drug-screening using 
iPSC-derived human cardiomyocytes. 
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Introduction 
 Fluorescent dye indicators for intracellular 
calcium measurement are widely used in many fields of 
biology. The fluorescent calcium indicator dyes work by 
their ability to change their brightness when bound to 
calcium ions. Fura-2 was one of the first calcium 
indicators developed and has a large spectral shift upon 
binding to calcium that allows for the ability to 
ratiometrically measure intracellular calcium 
concentration 1. Newer calcium indicators have minimal 
spectral shift upon calcium binding but are much 
brighter and are used for measuring qualitative changes 
in calcium concentration. FLIPR dyes were developed as 
a no-wash calcium dye to minimize the number of steps 
and washing artifacts important for high throughput 
applications 2, 3. FLIPR dyes come with background 
quenching technology which may improve SNRs and 
decrease standard deviation and dye loading does not 
require detergent. Cal-520 AM is the latest generation 
of fluorescence indicators in the line of Fluo3-AM and 
Fluo4-AM which are dyes linked to non-polar 
acetoxymethyl (AM) esters that allow for efficient 
crossing of the cell membrane and are rapidly 
hydrolyzed by esterases inside the cell. AM conjugated 
dyes are reconstituted in DMSO and may be used with a 
low concentration detergent, such as 0.04% Pluronic F-
127, to increase dye loading, which may be unphysio-
logical.  
 Calcium is a robust second messenger for cell 
physiology including contraction of muscle cells. 
Contractility of muscle cells especially cardiomyocytes 
plays a critical role in analyzing compound-induced 
cardiotoxicity in the drug discovery industry. Over 30% 
of drug discovery programs are terminated due to the 
cardiac safety concerns 4. While current cardiac safety 
guidelines for in vitro cardiac safety assessments focus 
on detecting drug-induced changes in electrophysiology, 
resulting in drug-induced arrhythmia such as Torsade 
de Pointes (TdP), electrophysiology assessments have 
limited sensitivity to detect new emerging types of 
cardiotoxicity issues including those induced by kinase 
inhibitors for cancer drugs 5. Calcium ions play an 
important part in electrophysiology and regulate the 
activities of motor proteins in cardiac contraction, which 
is known as excitation-contraction coupling 6. The 
assessment of calcium concentration allows analysis of 
cardiotoxicity issues in both electrophysiology and 
contractility 7. In addition, iPSC-derived cardiomyocytes 
will play a critical role in screening compound-induced 
cardiac safety issues in the early stages of the drug 
discovery process to avoid expensive drug attritions in 
their later stages. Therefore, we assessed the sensitivity 
of two calcium indicator dyes by analysis of CaTs from 
iPSC-derived cardiomyocytes to determine the effects of 
well-known proarrhythmic cardio toxic compounds on 
CaTs in high-throughput (HTP) assay format. The work 
describes an approach to perform such assays and 
statistical analysis to improve the confidence of data 
obtained from the HTP assays as well as to select 
appropriate calcium indicator dyes for different projects 
based on assay needs. 
Methods 
Cardiomyocyte Differentiation and Seeding 
 Human iPSCs (Applied Stem Cell, Milpitas, CA) 
were cultured (37°C, 5%-CO2) on matrigel-coated 6-
well plates in stem cell media and seeded into Matrigel-
coated 24-well plates for differentiation. Cardiomyo-
cytes were differentiated from human iPSCs following 
previously established methods 8. Beating cardiomyo-
cytes were maintained in Advanced RPMI 1640 Medium 
(GIBCO-Thermo Fisher Scientific, Grand Island, NY) 
with media exchange every 2 days. Cardiomyocytes 
were harvested 15-20 days after differentiation and 
were seeded into black, clear-bottom 96-well plates 
(Corning, Corning NY) at 100,000 cells/well (312,500 
cells/cm2). 
Calcium Dye Loading and Detection 
 On the day before the assay, the medium in the 
96-well plate was replaced with 100 µL Advanced RPMI 
1640 Medium per well. On the day of the assay, the 
medium in the plate incubated with the cells overnight 
(conditioned medium) was removed and stored at 37°C 
and 5% CO2. FLIPR Calcium 6 dye (Molecular Devices, 
Sunnyvale, CA) was mixed at 1:1 dye to medium and 
the mixture was added to the wells of plate. Cal-520 AM 
(AAT Bioquest, Sunnyvale, CA) was solubilized in DMSO 
at 2mM and diluted 1:1000 in medium for a final 
concentration of 2 µM with the addition of 1:100 
Powerload Concentrate, 100X (Thermo Fisher Scientific, 
Waltham, MA) and the mixture was added to the wells 
of the plate. Dye mixtures were incubated with the cells 
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for 60 minutes in the incubator (37°C, 5%-CO2). The 
dye was removed from the plate and the wells were 
washed with warmed medium 1X. The conditioned 
medium (stored at 37°C, 5%-CO2) was added to the 
cells, and the 96-well plate was stored in the incubator 
for >30 minutes before the assay. 
 Fluorescence readings were attained on a FDSS/
µCell (Hamamatsu, Japan) system with readings at ~110 
data points/sec for 60 seconds. The FDSS/ µCell has a 
heated stage that is maintained at 37°C during 
recording. Fluorescence measurements were recorded 
and the plate was returned to the incubator for 10 
minutes before the next recording. Two baseline 
measurements (T1, T2) were made prior to drug 
addition and a drug-treated measurement (T3). 
Drug Preparation and Addition 
 Dofetilide (Sigma-Aldrich, St. Louis, MO) was 
solubilized in DMSO at a stock concentration of 20mM 
and E-4031 (Sigma-Aldrich, St. Louis, MO) was 
solubilized in deionized water at a stock concentration of 
20mM. The stock concentrations of the drugs were 
diluted in medium to 10X the final concentration for the 
assay and added to a 96-well drug delivery plate. 0.1%-
DMSO time-matched controls were used for the “0” drug 
condition to control for solvent changes. The drugs 
dilutions were delivered to the 96-well cell plate using a 
CyBi-SELMA semi-automated electronic pipetting device 
with a 96-channel head (Analytik-Jena, Jena, Germany). 
Data Analysis 
 Each experimental condition in the plate had 
four replicates (n=4), and at least three similar 
experiments were performed. Data was analyzed with 
OscioSurf software (InvivoSciences, Inc., WI) designed 
to automatically detect number of periodic CaT peaks 
and analyze amplitude, peak-width duration changes, as 
well as perform ensemble average calculations of all the 
CaTs. Monte-Carlo simulation was processed in Microsoft 
Excel. 
Results 
 To assess the ability of FLIPR and Cal-520 
calcium dyes to detect CaTs for drug-screens in iPSC-
derived cardiomyocytes, we assayed cardiomyocytes 
that were seeded in 96-well plates and cultured for >7 
days. One half (48 wells) of the 96-well plate was loaded 
with FLIPR dye and the other half (48 wells) were 
loaded with Cal-520 dye and treated with two class III 
antiarrhythmic drugs, Dofetilide and E-4031 (See Figure 
1). They were chosen by their well-known effect of 
lengthening CaT-durations by blocking the rapid 
component of the delayed rectifier outward potassium 
current (IKr) which ultimately results in TdP and early-
after depolarization (EAD) 9, 10. Ensemble averages of 
CaT traces (n = 8-10) after drug treatment showed 
increased duration with increasing drug concentrations 
(1nM – 10 nM) (Figure 2A) and EAD at the highest 
concentrations (10 – 30 nM) (See Figure S2). Dofetilide 
Figure 1. Experimental approach for the calcium assay and drug addition. 
A) Schematic sequence for the optical measurements (read 1,2,3) and 
drug addition. B) Plate map shows location of FLIPR and Cal-520 loaded 
wells in a single 96-well plate before and after adding varying concentra-
tions of dofetilide and E-4031.  
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decreased CaT amplitudes significantly at higher 
concentrations (>3 nM) (Figure 2B). A similar decrease 
in amplitude was observed in analysis using E-4031 at 
>10 nM (Figure 2D). FLIPR was more sensitive than Cal-
520 to detect elongation of CaT duration-90 (CaTD-90), 
especially those treated with dofetilide at 3 – 10 nM 
(Figure 2C, E). 
 To assess the sensitivities for detecting effects 
of compounds on amplitudes and durations of CaTs 
systematically for decision making, specifically with 
respect to optimal hit (or safety for toxicity) criteria, we 
analyzed the data using Monte-Carlo statistical 
simulation. Monte-Carlo bootstrapping was used to 
generate data sets from the extant untreated and 
solvent control data via resampling with replacement 11, 
12. This was done for each metric (CaTD and Amplitude) 
and each dye (FLIPR and Cal-520). This approach was 
used primarily because it is free of a distribution 
assumption; while it is possible that standard statistical 
techniques could be applied to these data, possible 
skewness in the sampling distribution of values can be 
better accounted for using this approach (See Figure 
S1). 
 For amplitude, we noted a strong correspond-
ence between the first untreated baseline measurement 
value and both the second baseline measurement and 
the post-treatment measurement of untreated wells 
(See Figure 3A-B), indicating that a comparison of post-
treatment values could be done with the first 
pretreatment measurement without issues of additional 
temporal drift. Two methods were considered: 
Difference in average between two n=4 samples, and 
standardized difference (i.e., difference in average 
divided by pooled standard deviation). 10,000 pairs of 
n=4 data sets were generated using resampling with 
replacement of the first pretreatment measurement, and 
the resulting 10,000 metrics associated with these 
simulated data were calculated. Then, the 95th 
percentile of the set was determined, and compared to 
the actual value associated with treatment by dofetilide 
and E4031. The results, as shown in Figure 4A-B, 
indicate that a simple difference metric distinguished 3 – 
10 nM of both compounds as hits, except for E4031 
paired with Cal-520.  There were no false positives. In 
contrast, using the standardized metric, while there was 
better demarcation for dofetilide at 1 nM with Cal-520, 
this method applied to Cal-520 was unable to detect as 
hits any E4031 values, and included dofetilide false 
positives. Thus, for amplitude simple differences in 
average appears to be a better method for determining 
screening hits with this approach. 
 In contrast to amplitude, TD90 showed an 
increase by comparing the first baseline measurement 
and the second (see Figure 3C-D). Because of this, while 
we again considered the standardized and unstandard-
ized metrics for TD90, we used the first pretreatment 
measurement as baseline for the second, and the 
second pretreatment measurement as baseline for the 
post-treatment measurement. Considering the roughly 
equally spaced time measurements, the underlying 
assumption here that the temporal drift of the numerical 
values is constant is appropriate. The results are shown 
in Figure 4C-D. For FLIPR, both methods performed 
equally well, differentiating both dofetilide and E4031 as 
hits even at the 1 nM dose. For Cal-520, the 
standardized method worked equally well, but the 
simple difference showed a strong false-positive 
problem. Thus, the standardized method appears to be 
the better approach for TD90, in contrast to amplitude. 
Discussion 
 FLIPR Calcium 6 and Cal-520 AM are the latest 
generation of fluorescence calcium indicators currently 
on the market. FLIPR is designed as a no-wash dye with 
its quencher, but Cal-520 can also be used without 
washing. Additionally, both dyes retain fluorescence 
signal for several hours after a washing step. The 
fluorescence signal from FLIPR is larger after washing 
due to removal of the quencher. It may be favorable to 
use without the quencher in some cases, although 
accurate measurement of intracellular calcium levels 
may be better with the quencher on due to a reduction 
in non-specific fluorescence or auto-fluorescence 13. Cal
-520 AM has the advantage of being widely used for 
many application such as detecting the activation of 
neurons and can be prepared at any concentration for 
the appropriate assay. Cal-520 AM does not have a 
fluorescence quencher; therefore some non-specific 
fluorescence may influence the measurements. In 
addition to Cal-520 AM, AM conjugated calcium 
indicators with different excitation and emission are 
available (Cal-590 AM, Cal-630 AM). While Cal-520 may 
have a similar affinity for calcium compared to previous 
generation dyes (Cal-520, Kd = 320nM; Fluo-3, Kd = 
  
Freely Available  Online 
www.openaccesspub.org  |  JESR               CC-license        DOI : 10.14302/issn.2574-4372.jesr-16-1395      Vol-1 Issue 2Pg. no.  5  
 
Figure 2. Analysis of CaT profiles drug-treated iPSC-derived cardiomyocytes measured 
using FLIPR and Cal-520 calcium dye.  FLIPR and Cal-520 loaded iPSC-derived cardiomyo-
cytes treated with increasing concentrations of dofetilide and E4031 and analysis of (A) 
average traces, (B) and (D) amplitude, (C) and (E) CaT duration-90. Asterix (*) indicates 
a significant difference (P<0.05) from vehicle-treated groups by t-test analysis and a 
number above the bar indicates the fraction of the total number of wells where traces 
showed EAD and were not included in the analysis. Percent changes were computed by 
100 X (Treated Read3-Pretreated Read2)/(Pretreated Read2) for each well. There was no 
significant difference between no treatment and vehicle treated groups.  
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Figure 3. Stability of measurement reads from untreated/solvent treated control wells. A-D) The first 
untreated measurement (x-axis) was compared with the second untreated measurement (y-axis, red) 
and post-treatment measurement (y-axis, blue) of the untreated/solvent control wells for each dye and 
activity metric. E) Bar graphs corresponding to the data in (A-D). 
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325nM; Fluo-4, Kd = 345nM) which can depend on 
testing conditions (i.e. temperature, medium), it has 
improved binding specificity for calcium ions, reduced 
autofluorescence, increased SNR, and has better 
localization to the cytosol. FLIPR Calcium 6 has a similar 
binding affinity to calcium (Kd = ~320nM) and also has 
improvements over previous generation indicators with a 
higher quantum yield, increased signal window, and is 
better retained inside the cell. 
 Dofetilide was reported to exhibit prolongation 
of the QTc interval at very low (3.4nM) total plasma 
concentrations 14. Results from this study indicate that 
FLIPR Calcium 6 and Cal-520 AM can detect elongation 
of CaTs with similar efficiency using human cardiomyo-
cytes derived from iPSCs. However, our analysis 
detected elongations of CaT durations at 1nM of both 
compounds. This can originate from the inherent high 
sensitivity of human iPSC-derived cardiomyocytes to 
proarrhythmic compounds due to their immaturity 15. 
Nonetheless, the sensitivities and other differences 
between human iPSC derived cardiomyocytes and 
human hearts have been evaluated systematically and 
blindly 16. The iPSC derived cardiomyocytes used in this 
study are >15-20 days post-differentiation, and 
spontaneously beating. Researchers have shown that 
iPSC-derived cardiomyocytes that are >16 days post-
differentiation start to segregate into cellular sub-types, 
and show pronounced sarcomeric structures 17. Young 
Figure 4. Results of Monte-Carlo hit-definition process, for each 
dye, compound, activity (amplitude and TD90) metric, and simula-
tion (differences in averages and standardized differences) metric.  
Green indicates a hit; indicating potential well that are different 
from untreated/solvent control. Both compounds are specific in-
hibits of the delayed rectifier human ether-a-go-go-related gene 
(hERG) potassium channels, which is the rapid component of the 
delayed rectifier potassium current, known as IKr. The hERG inhi-
bition is expected to elongate TD90 but does not have much ef-
fect on amplitude of calcium transients. The data representing the 
highest concentration of both compounds were excluded because 
of their irregular traces shown in Figure S2.  
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iPSC-derived cardiomyocytes show signs of maturation 
that can be increased by longer culturing and are still 
considered immature compared to adult heart cells, but 
nevertheless can be used in drug screening assays 
despite their limitations. 
 Cellular responses to two class III antiarrhyth-
mic drugs, dofetilide and E-4031, were similar although 
increases in duration were slightly longer with FLIPR 
(Figure 2). These differences suggest that dyes for 
optical imaging may influence transient shape and is 
thus an important factor to consider when designing an 
assay for drug-screening. CaT amplitude was very stable 
across different measurements of the plate, in contrast 
to CaT duration which was highly dependent on the 
conditions of the plate (i.e. temperature, % CO2) and 
tended to increase during measurement, as also 
reported previously 18. This emphasizes the importance 
of maintaining the plate as closely as possible to 
incubation conditions during plate readings and 
designing an assay flow and analysis to avoid detecting 
false positives. For assessing drug-screening hit 
selection, Monte-Carlo simulation can be useful for 
determining the optimal hit criteria for analysis and 
accounting for non-normal distribution as well as 
sampling limitations 11, 12. 
Conclusions 
 FLIPR Calcium 6 and Cal-520 AM are the latest 
and most advanced intracellular calcium indicators 
available. Both dyes are suitable dyes for detecting CaTs 
from iPSC-derived cardiomyocytes and reporting CaT 
shape and dynamics (amplitude, CaTD-90) with more 
than sufficient SNR. FLIPR Calcium 6 and Cal-520 AM 
are particularly well designed for high throughput 
applications and will greatly aid the development of 
cardiotoxicity assays for drug development. In summary, 
selection of optical reporter dye and analysis for hit-
selection criteria are important factors for successful 
drug-screening. 
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Figure S1. Examples of the distribution of outputs of Monte-Carlo simulation, representing the approxi-
mate sample distribution of the differences in n=4 averages  (Blue).  In Red, a Normal distribution in 
given for comparison.  Note that A) and D) look approximately Normal, while B) and C) show non-
Normal skewness, indicating the appropriateness of Monte-Carlo bootstrapping for these circumstances. 
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Figure S2.  CaT traces of FLIPR and Cal-520 stained cardiomyocytes treated with the highest concen-
tration of Dofetilide and E-4031. All wells exhibited irregular CaT traces displaying varying degrees of 
EAD.  
